FDA slams Dollar Tree for purchasing drugs from suppliers with checkered safety records
Dollar Tree purchased drugs from foreign companies that failed to follow manufacturing standard, displaying a pattern of serious violations, the FDA said in a warning letter.
by Ed Silverman
Nov 14, 2019
2 minutes
Amid growing concerns over the pharmaceutical supply chain, regulators sternly warned the Dollar Tree (DLTR), which runs a vast network of stores serving mostly low-income communities, for selling over-the-counter medicines made by companies that failed to ensure the drugs were safely manufactured and tested.
In a , the Food and Drug Administration noted the retailer purchased medicines
You’re reading a preview, subscribe to read more.
Start your free 30 days